SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.80-0.1%Nov 21 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dan O who wrote (7056)8/28/1998 8:20:00 PM
From: Robert K.  Read Replies (2) of 17367
 
Great info and footwork guys & gals. If all is to be believed, then this is a false alarm HOWEVER, lets get some verification.>from Ellen<.

ALSO let me say this, I was thinking about takeovers etc.
Hostile and non hostile.
Hostile>probably difficult with poison pill
non-Hostile>Gotta be a high price or a total sell out by management.
Which brings me to how xoma looks as a target.
No patent disputes.
No collaborations or partners to worry about.
Low price.
Big potential.
P3's
Looks like a nice clean target to a suitor.
IMO would have to be non hostile and costly.
Opinions?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News